Page last updated: 2024-08-23

moxalactam and Central Nervous System Disease

moxalactam has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avery, GS; Brogden, RN; Carmine, AA; Heel, RC; Romankiewicz, JA; Speight, TM	1

Reviews

1 review(s) available for moxalactam and Central Nervous System Disease

Article	Year
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 1983, Volume: 26, Issue:4 Topics: Absorption; Adult; Aminoglycosides; Bacteria, Anaerobic; Central Nervous System Diseases; Child; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Infant, Newborn; Inflammation; Kidney Diseases; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Sepsis; Staphylococcus; Streptococcus; Tissue Distribution; Urinary Tract Infections	1983

Article

Year

Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Drugs, 1983, Volume: 26, Issue:4

Topics: Absorption; Adult; Aminoglycosides; Bacteria, Anaerobic; Central Nervous System Diseases; Child; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Infant, Newborn; Inflammation; Kidney Diseases; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Sepsis; Staphylococcus; Streptococcus; Tissue Distribution; Urinary Tract Infections

1983